Najat Khan sells 124,403 Recursion Pharmaceuticals (NASDAQ: RXRX) shares

Rhea-AI Filing Summary

Recursion Pharmaceuticals reported an insider transaction: Najat Khan sold 124,403 common shares on 12/22/2025 for $548,587.96. The filing also lists a planned equity compensation sale of 28,298 common shares dated 02/15/2026. The report is a Form 144 disclosure of resale activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 301 Tresser Blvd. Stamford CT 06901	28298	94662.47	521950663	03/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2026	Equity Compensation	Recursion Pharmaceuticals			28298	02/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Najat Khan 41 S Rio Grande Street Salt Lake City UT 84101	Common	12/22/2025	124403	548587.96

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 for RXRX disclose?

The Form 144 discloses an insider sale by Najat Khan of 124,403 common shares on 12/22/2025, generating $548,587.96. It also lists an equity compensation entry for 28,298 shares dated 02/15/2026.

Who sold shares of RXRX in the filing?

The filing identifies Najat Khan as the selling party, with an address listed in Salt Lake City, UT. The transaction reported is the sale of 124,403 common shares on 12/22/2025.

How much proceeds were reported for the RXRX insider sale?

Proceeds shown for the sale on 12/22/2025 are $548,587.96 for 124,403 common shares. The filing ties this amount directly to the reported transaction by Najat Khan.

Does the filing show planned future sales for RXRX insiders?

Yes; the report includes an Equity Compensation entry dated 02/15/2026 for 28,298 common shares. The entry is listed under securities to be sold on that date.

What form was used to report the RXRX transaction and what does it mean?

The transaction was reported on Form 144, which discloses an insider's resale of restricted or control securities. It signals a registered resale filing rather than a company announcement or earnings event.